Wiley BROS. Aintree Capital LLC purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 4,897 shares of the company’s stock, valued at approximately $1,486,000. HCA Healthcare comprises about 0.7% of Wiley BROS. Aintree Capital LLC’s investment portfolio, making the stock its 27th largest position.
Several other large investors also recently bought and sold shares of HCA. EP Wealth Advisors LLC acquired a new stake in HCA Healthcare in the 1st quarter valued at about $210,000. Level Four Advisory Services LLC increased its holdings in HCA Healthcare by 2.8% in the 1st quarter. Level Four Advisory Services LLC now owns 2,525 shares of the company’s stock valued at $666,000 after purchasing an additional 69 shares during the last quarter. Fortis Group Advisors LLC acquired a new position in HCA Healthcare during the first quarter worth $5,977,000. ProShare Advisors LLC raised its holdings in shares of HCA Healthcare by 6.8% in the 1st quarter. ProShare Advisors LLC now owns 32,764 shares of the company’s stock valued at $8,639,000 after buying an additional 2,074 shares during the period. Finally, Old North State Trust LLC boosted its holdings in HCA Healthcare by 273.1% during the 1st quarter. Old North State Trust LLC now owns 806 shares of the company’s stock valued at $57,000 after acquiring an additional 590 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
HCA has been the topic of several recent research reports. 1-800-FLOWERS.COM reaffirmed a “maintains” rating on shares of HCA Healthcare in a research note on Wednesday, June 28th. Barclays lifted their price objective on HCA Healthcare from $275.00 to $300.00 in a research note on Wednesday, June 28th. StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Tuesday. Oppenheimer lifted their price objective on shares of HCA Healthcare from $310.00 to $315.00 and gave the stock an “outperform” rating in a research report on Friday, July 28th. Finally, VNET Group restated a “maintains” rating on shares of HCA Healthcare in a research note on Wednesday, June 28th. Two investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $310.36.
HCA Healthcare Stock Performance
Shares of HCA traded up $0.37 during mid-day trading on Thursday, hitting $262.86. 150,533 shares of the company’s stock were exchanged, compared to its average volume of 1,267,815. The firm has a market capitalization of $71.49 billion, a P/E ratio of 12.91, a P/E/G ratio of 1.40 and a beta of 1.60. The business’s 50 day moving average is $278.46 and its two-hundred day moving average is $273.76. The company has a current ratio of 1.20, a quick ratio of 1.03 and a debt-to-equity ratio of 79.26. HCA Healthcare, Inc. has a fifty-two week low of $178.32 and a fifty-two week high of $304.86.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Thursday, July 27th. The company reported $4.29 EPS for the quarter, topping analysts’ consensus estimates of $4.28 by $0.01. HCA Healthcare had a net margin of 9.32% and a negative return on equity of 12,765.76%. The firm had revenue of $15.86 billion for the quarter, compared to the consensus estimate of $15.63 billion. During the same quarter in the previous year, the firm earned $4.21 earnings per share. The firm’s revenue was up 7.0% on a year-over-year basis. On average, equities analysts expect that HCA Healthcare, Inc. will post 18.44 earnings per share for the current year.
HCA Healthcare Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 15th will be paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.91%. The ex-dividend date is Thursday, September 14th. HCA Healthcare’s payout ratio is currently 11.81%.
In other news, SVP Jeffrey E. Cohen sold 1,500 shares of HCA Healthcare stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $270.00, for a total transaction of $405,000.00. Following the completion of the sale, the senior vice president now directly owns 4,414 shares in the company, valued at $1,191,780. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,916 shares of the stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $270.00, for a total transaction of $787,320.00. Following the transaction, the senior vice president now owns 10,250 shares of the company’s stock, valued at $2,767,500. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Jeffrey E. Cohen sold 1,500 shares of the stock in a transaction on Friday, August 11th. The stock was sold at an average price of $270.00, for a total value of $405,000.00. Following the completion of the transaction, the senior vice president now directly owns 4,414 shares in the company, valued at $1,191,780. The disclosure for this sale can be found here. Insiders have sold 9,620 shares of company stock worth $2,592,820 over the last three months. 1.60% of the stock is currently owned by corporate insiders.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
- Five stocks we like better than HCA Healthcare
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- WeWork Stock Soars: Meme Stock Madness or Mirage?
- What is Insider Trading? What You Can Learn from Insider Trading
- Shutterstock is the Value Stock they don’t want you to know about
- How is Compound Interest Calculated?
- 3 Low-Cost ETFs That Are Crushing SPY
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.